Medical Devices Industry: January 2015

Wednesday, 28 January 2015

Global Market for Respiratory Monitoring Devices – Industry Segment and Forecast, 2013 - 2019

Respiratory monitoring devices are used for monitoring the respiration rate and are better known as heart-respiratory monitors due to their uses in heart monitoring. Such devices are utilized in hospitals on patients who face risks of apnea, and in some cases used at home as well. The monitor uses several patches placed on the body to measure the heart rate and the breathing rate responding to the body’s movement and then transmits the data to the attached leads. The respiratory monitor comprises of a monitor that displays and logs the value in real-time so that the care team can analyze the values at different points of time. Increase in the sales of portable respiratory monitoring systems due to increasing risks of sudden infant death syndrome, increasing respiratory problems among individuals, along with continuous improvement in technologies are among the key drivers of the respiratory monitoring device market.

The market for respiratory monitoring includes a variety of monitoring products, including a specialty version designed for infants. Oximeter, a device that is attached to the finger and is used to track oxygen levels in the blood, an arm or a wrist cuff, a device that is used to measure blood pressure, and patches are the products under this market. Geographically, the market is broadly divided into the Americas, EPEA, and APAC regions with APAC having the maximum potential for growth.

The market for respiratory monitoring devices suffers certain restraints during the current period such as – decrease in product differentiation and low per capita income in developing nations, but as the world is moving towards development, the rise of economies will boost the demand for respiratory monitoring devices as people will have more disposable income. Some of the market players of this market are CareFusion Corp., Covidien Plc, Draegerwerk AG and Co., GE Healthcare Ltd., Philips Healthcare, Siemens Healthcare, and ResMed Inc.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1415

Browse Market Research Blogs:

http://researchreportsindustry.wordpress.com/

Global Report on Sterilization Market - Industry Segment and Forecast, 2013 - 2019

The term sterilization refers to any procedure that helps in destroying all forms of microbial life and transmissible agents. Transmissible agents are bacteria, fungi, spore forms and virus. These micro-organisms and transmissible agents are present on the surface of medical instruments, contained in medication, fluid and biological culture media. Sterilization helps in making these culture media infection free by applying heat, pressure, chemical and filtration. This process disables the infectious protein like prions of the micro-organism and hence results in infection free medium.

Sterilization is achieved through various methods such as steam sterilization, heat sterilization, chemical sterilization, radiation and sterile filtration. In steam and heat sterilization, the artifacts which are to be sterilized are placed in a steel container and subjected to high temperature. These containers are incorporated with numerous parts that help in maintaining temperature and pressure inside the container. In chemical sterilization, various chemicals such as ethylene oxide, nitrogen dioxide, bleach, ozone, phthalaldehyde, glutaraldehyde, formaldehyde, hydrogen peroxide, peracetic acid, and silver are used. In radiation sterilization, rays like gamma, ultraviolet, electron beam and X-rays are used. These processes may sometime destroy liquid medium along with the micro-organism. To overcome this situation, sterile filtration is performed where the fluids are passed through very minute pores whose size ranges from 20 to 50 nm. These small pores do not allow the micro-organism to pass since size of these organisms is larger than the pores.

This market is expected to grow due to rise in safety processes of the various medical institution and research laboratories. In addition rise in number of surgeries and would consequently increase the demand of infection free instruments. In addition, drug preparations also require high sterile medium which would also augment the growth of this market. Moreover, the governments have made stringent rules for various medical institutes to sterile instruments after every use which would also trigger the growth of this market.

Some of the market players in this industry segment are Roche, Pfizer, Becton Dickinson, Advanced Sterilization Products, Belimed AG and bioMerieux amongst other significant players.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2118

Browse Market Research Blog:

http://researchreportsindustry.wordpress.com/

Tuesday, 27 January 2015

Measles Testing Market - Global Industry Analysis, Trends and Forecast 2014 – 2020

Measles also referred to as morbilli or rubeola is an infection caused by virus known as paramyxovirus which belongs to genus morbillivirus. Measles is an infection of immune system, respiratory system and skin. It is a highly contagious respiratory disease, typically occurring due to more than 90% of the household contacts and more than 50% contact in the day care centers or school. Measles is observed to be spread through respiratory contact with infected person’s nose and mouth fluid or directly through aerosol transmission. Initially patients infected with show symptoms such as cough, inflamed eyes, fever, sore throat, fever, runny nose, and red blotchy skin rash. Later, with the disease progression the patients show symptoms of diarrhea, pneumonia and spot like rashes that covers the entire body. Among all the measles case reported only 10% of the cases are complicated and for every ten children developing encephalitis measles die and up to four show permanent brain damage. Subacute sclerosing panencephalitis (SSPE), which causes progressive brain degeneration is a late complication of measles and occurs in about 1 in 25,000 cases.

Measles is commonly a disease of children and in most of the developed countries children are immunized against measles by the age of 18 months. Measles vaccines are generally part of MMR vaccine (mumps, measles and rubella) vaccine. The vaccination is generally not prescribed before 18 months as sufficient amount of immunoglobulins are acquired by the new born through mother’s placenta. A second dose of vaccine is usually administered during the age of four and five, to increase the rate of immunity. Hence, in developed countries to control the prevalence of measles vaccination rate are high. However, in developing countries two doses of measles vaccination are prescribed at the age of six months and two months. In addition to vaccination, serological diagnosis is also performed for the identification of measles infection. In these test diagnosis of IgG and IgM antibodies is performed for the diagnosis of infection. The global market for measles testing can be segmented on the basis of diagnostic tests, instruments, technologies and end users. End users section of the report can be analyzed on the basis of physician offices, public health laboratories and commercial and private laboratories.

The global market for measles testing is expected to record significant growth rate in the near future. The growth would be observed due to advancement in immunodiagnostic technologies and automation. Additionally growth in this industry would be fuelled by entry of new market players, growing awareness about the disease and outbreaks of the infection in the developing countries. For instance, in 2007 in Japan large number of institutions and other industries were closed as an attempt to contain the disease. Additionally as per the WHO approximately 158,000 deaths were caused due to measles in 2011. Hence, increasing prevalence of the infection would increase the demand for measles testing.

North America is observed to be the largest market for measles testing due to presence of major market players based in this region. According the Centers for Disease Control and prevention from January 1st 2014 to April 2014 approximately 6,000 confirmed and 26,000 suspected cases of measles have been reported in Philippines. Hence, increasing cases of patient diagnosed with measles would further trigger the growth in this market. Europe is expected to record the second position in the global measles testing market.

Abbott Laboratories, Biomedical Diagnostics, Bio-Rad, Dako, Beckman Coulter, BioMerieux, DiaSorin, Eiken and Ortho-Clinical Diagnostics and others are some of the major players operating in clinical chemistry and immunodiagnostics market.

More Reports on Medical Devices Market : http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3979

Aeromonads Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Aeromonads is genus comprising of gram negative bacteria. These are non spore forming, rod shaped bacteria and require anaerobic environment for growth. Aeromonads bacteria are widely distributed in fresh water bodies and marine water environment. These can grow at large range of temperatures, and causes wide spectrum of infectious diseases in warm and cold blooded animals such as fishes, amphibians, reptiles, mammals and humans as well. The genus Aeromonads consist of more than 13 species out of which Aeromonads hydrophila, Aeromonads caviae, Aeromonads sobria, Aeromonads veronii, and Aeromonads schubertii, and Aeromonads salmonicida are responsible for infections in humans.

An Aeromonads bacteria affects human in two major diseases forms namely gastroenteritis and wound infection. The infection relating to gastroenteritis is associated with diarrheal illness and septicemia along with nausea and vomiting. The later stage of this infection can cause severe colitis and pancreatitis. This can affect humans across all ages and both genders, whereas majority of the infections are acquired by foreign travelling. There are very few cases of wound infection but can be fatal if not diagnosed and treated early. Now days there are cases emerging of Aeromonad infection in Urinary Tract, respiratory tract and dermal surface of the body. Aeromonad diagnosis is vital part of treatment because of its resistance to various antibiotics such as erythromycin, cephalosporin, and penicillin.

Though the microorganism has presence in entire world, according to a research study Aeromonads infection cases occurs more in developing countries due to contamination of drinking water, consuming infected foods among other factors. Geographically Aeromonads infection cases can be segmented in Asia Pacific regions, Africa, Europe, South America and North America. A report mentioned that in 2012, out of total diarrheal cases of travelers to developing countries, 2% are because of Aeromonads infections. The delayed or improper treatment can cause even death or life threatening diseases in infected people. As Aeromonads infections symptoms mimic other infections it is critical to diagnose Aeromonads infection in humans.

There are several methods for identification and diagnosis of Aeromonads infection which includes culture cultivation technique, enzyme linked immunoassay (ELISA) technique and the advanced PCR assay testing by isolation of bacteria DNA. This is the most accurate and reliable method of diagnosing presence of Aeromonads infection but at the same time is involves significant cost and training. This process comprises of rapid isolation of high quality DNA with high sensitivity and specificity which are then compared and recognized.

Aeromonads infections occurs among people from developed countries such as The USA, Europe and major countries within the region, Japan, Australia, frequent travelers to African region, Middle Eastern and Asian countries. This infection is also causing considerable burden on various economies in the world and ultimately costing millions of dollars to the governments on healthcare expenditure. Therefore market for diagnostic testing of Aeromonads infection will continue to grow. The market for Aeromonads diagnostic testing can be divided industry wise among food processing industry, hospitals, government agencies such as municipal corporations, aquatic or marine animal based industries and different academic institutions.

Some of the key players in Aeromonads infection diagnosis testing market are Hardy Diagnostics, Becton Dickinson and Company, DuPont Qualicon, Thermo Scientific, Life Technologies, AmpliSens Biotechnologies and Qiagen.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3978

Monday, 26 January 2015

US Image Guided Surgery Industry Strategies and Forecast up to 2020

Image guided surgery makes use of preoperative images to precisely guide surgical instruments by correlating the operative field. The image guidance systems also help in seamless procedure planning, thus reducing chances of error and also minimizing procedure time. With image guided systems, overall productivity is increased and being minimally invasive, allows quick recovery and shorter hospital stay. The technique was initially developed for neurosurgeries, which is one of the most critical procedures. ENT surgeries still remain the main area of application of image guided surgery systems. Major indications where image guided surgery can be performed are sinus surgery, and treatment of diseases which critical areas of cerebrum where chances of error must be minimum. Oncology is a major area of application of image guided surgery, where various methods are tried and tested for efficient treatment. With the development of technology and optimization of procedures, image guided surgery is expected to be the main stay for neurological surgeries, especially in treatment of brain tumor.

Ultrasound, magnetic resonance imaging (MRI) and computed topography (CT) are majorly applied in image guidance systems. Fluorescence image guided surgery is also becoming popular, as it cost effective as compared to other devices, but poor depth penetration is a restraint. Fluorescent dyes are used to stain the abnormal tissues and light with different filters is used for visualization. Indocyanine green and methylene blue are commonly used dyes for fluorescence image guided surgery. This technology has been further refined by combining it with endoscopy devices. Robot assisted surgeries have also helped in minimizing errors during surgery and have also helped surgeons to carry out critical surgeries effectively.

These robot assisted systems are also combined with image guided surgery systems. Brainlab manufactured Curve Image Guided Surgery Systems and MAKO manufactured MAKOplasty systems are few examples of latest technology robot assisted image guided surgery systems. Advent of high definition (HD) and three dimensional (3D) visualization systems have further revolutionized the image guided surgery systems by improving image quality and improving depth perception. Ergonomic and miniaturized devices have made procedures convenient to surgeons. These factors will increase the adoption of image guided surgery systems and hence assist market growth.

Statistics published by National Cancer Institute, U.S. indicate that there were more than 150,000 individuals diagnosed with some type of cancer of nervous system including brain cancer in the U.S. alone. The statistics also estimated approximately 14,000 new cases may arise by 2014 in the U.S. According to a healthcare website, MedIndia, primary brain tumor accounts for 20% of the cancers in pediatrics in India. Such high prevalence and ever increasing burden will increase the customer base for image guided surgery market globally.

Higher cost however is restraining the market growth in developing countries where hospitals do not have enough funds to upgrade their hospitals to expensive latest technology. Moreover lack of skilled surgeons for image guided surgery is also a major factor affecting its adoption. Furthermore patients in developing and under developed countries do not have the basic ability to pay for expensive treatments and hence opt for cost effective surgeries options. Hence the market for image guided surgeries is currently abominated by North American and European countries. Favorable reimbursement policies, surgeon training and development events, well equipped hospitals are driving the market. Some of the key players in this market include MAKO Surgical Corp. (acquired by Stryker), Medtronic, Brainlab AG, Scopis Medical, Claron Technology, Inc., and GE Healthcare.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2541

Clinical Management of Intra-Dialytic Hypotension Market Report till 2020

Most of the people who are suffering from end-stage renal disease undergo hemodialysis, and is often accompanied by recurrent and troubling side-effects, which are referred to as intra-dialytic hypotension (IDH). IDH has been estimated to affect around 15% to 55% of all patients undergoing hemodialysis. Some of the major symptoms of IDH include nausea, diaphoresis and cramps, to more precarious conditions that include angina pectoris, arrhythmias, seizures, unconsciousness and even cardiac arrests. IDH is mainly caused due to inefficient cardiovascular response to the reduced blood volume, which is bound to occur due to the removal of large volumes of water in a very short span. As a typical hemodialysis procedure involves the removal of an ultrafiltrate volume of water from the patient’s body, which is equal to or even greater than the entire blood plasma of the patient.

The occurrence of IDH would increase further due to ageing population that exhibit greater comorbidities, such as cardiovascular problems and diabetes, thus making IDH a problem that requires extensive rethinking and innovation. Several drug developers and manufacturers are involved in extensive research and development and many of them have a considerable number of drugs in different stages of clinical trials in this field. Some of the important drugs that are in different stages of clinical trials that will soon be commercialized in the global market include, MTR107, Droxidopa, Mannitol, Northera and Norathiol among others.

Some of the major driving factors for the growth of this market include, high number of patients undergoing hemodialysis, aging population, rising demand for advanced therapeutics, high number of drugs in the pipeline and rising awareness and affordability of the people globally. At present, many people are undergoing hemodialysis due to kidney failure or end stage renal diseases, which in turn increase the chances of developing IDH, thus, will contribute towards the growth of this market in future. Also, aged individuals increasingly require hemodialysis, hence are more prone towards IDH, hence will add to this market’s growth in future. Comorbidities such as, diabetes and cardiovascular diseases also increase the chances of developing renal disorders, hence in turn will increase IDH occurrences, hence the demand for advanced therapeutics. Thus, rising awareness and demand along with high number of pipeline drugs that will soon be commercialized in the global market will augment the growth of this market in the near future.

Geographically, North America and Europe are expected to dominate the global intra-dialytic hypotension market. Some of the key factors that are expected to be responsible for their dominance in this market are high number of patients undergoing renal hemodialysis along with the presence of large geriatric population in these regions. Most of the companies that are involved in the research and development activities in this field and have a few drugs in the pipeline also belong to these regions. Thus, it is expected that these regions will largely dominate this market in future. However, Asia Pacific that constitutes some of the fastest emerging economies of the world along with increasing number of patients with renal diseases will help grow this market in this region in future.

Some of the major players having their drugs in different stages of clinical trials in this market include, Advanced Circulatory Systems, Inc., B. Braun Melsungen AG, Chelsea Therapeutics, Inc., Global Monitors, Inc., Medinox, Inc., Meditor Pharmaceuticals Ltd. and Wolfson Medical Center.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3164

Thursday, 15 January 2015

2019 Strategies for Respiratory Syncytial Virus Diagnostic Testing Industry

Respiratory syncytial virus (RSV) causes infection of respiratory system (lungs and breathing passage). It may also affect heart and immune system resulting in more serious illnesses (e.g. tachypnea, cyanosis).Premature infants (30-40 days) and children (less than 2 year of age) are at the highest risk of this infection. According to the U.S. Centre for Disease Control and Prevention (CDC), RSV is the common cause of bronchiolitis or pneumonia in the children under one year of age in the United States. Each year 75,000 to 125,000 children are hospitalized due to RSV infections. This Infection can result from the direct (i.e. kiss, touch or shake hands with infected person) or indirect contact (i.e. contact with sneeze, cough or blows of infected person)with the infected person. Mild headache, runny nose, cough and sore throat are some of the common symptoms of RSV viral infections. Diagnosis of these infections is facilitated by specific tests like polymerase chain reaction assay, molecular probes, chest radiography. Physicians also administer intubation (breathing tube), mechanical ventilation or some antibiotics (like palivizumab) in order to treat the patients with RSV infections.

Increasing incidences of childhood pneumonia, acts as one of the major factors to drive the growth of RSV diagnostic testing market. According to the data enumerated by World Health Organization (WHO), in 2010, approximately 1.1 million people in the United States were hospitalized with pneumonia and 50,000 people died from this disease. In addition, crowded population and unhygienic environment (dirty premises, unhygienic eating places) may increase the chances of RSV infection thereby resulting in increased need and demand for effective RSV diagnostic tests. However, high number of other pathogens that may cause similar symptoms of respiratory illness and lack of availability of specific treatment options to curb this infection may restrain the growth of this market.

The global Respiratory Syncytial Virus Diagnostic Testing Market can be segmented as follows:

By Diagnostic Technology

Molecular Diagnostics
Immunoassays
Monoclonal Antibodies
Flow Cytometry
Diagnostic Imaging
Chromatography
Gel Microdroplets
Others

By End Users

Physician offices or group practices
Hospitals
Commercial Laboratories
Nursing Homes

Geographically, North America and Europe dominate the global RSV diagnostic testing market due to increasing patient population suffering from respiratory syncytial virus. According to the U.S. CDC, approximately 50,000 deaths are noted due to pneumonia in the United States in year of 2012.In addition, Asia-Pacific countries such as India and China, South East Asian countries are the emerging regions for global RSV diagnostic testing market due to high prevalence of these diseases (i.e. pneumonia, bronchitis) in these regions and increasing healthcare awareness.

Some of the key players in this industry are Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, bioMerieux, F. Hoffman-La Roche, Ltd., Bio-Rad Laboratories, Inc., DiaSorin S.p.A , Novartis Diagnostics, Becton Dickson company and Thermo Fisher Scientific among others.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2065

U.S. Market for Current and Emerging Wound Closure Devices 2010 - 2017

Wound closure devices are apparatus that help in closing a wound by pulling the edges of the wound tissue together and aid in healing. Devices such as sutures, staples, adhesives, mechanical wound closure devices and strips aid in lending strength and tissue to the wound tissue, minimize tissue trauma and reduce risk of infection and excess scaring.

We cover the global wound closure devices market, discussing a detailed overview of the industry, its emergence, development and forecast. The industry has grown with the evolution of medical science and technology, and TMR’s report tracks the growth of the market at its various stages. It highlights the major factors that have strongly influenced the market and helped increase its popularity and demand. It also identifies the challenges faced, while offering strategies and suggestions to overcome the same.

The report segments the market based on products, applications and geography, and also lists leading companies that operate in the global wounds closure devices market along with their financial and sales profiles.

Overview of the global wound closure devices market

Each device has its own functions and needs, and may vary in design and size. Sutures, both absorbable and non-absorbable, dominate the wound closure devices market since they are used in almost every form of surgery. Sutures can be divided into two categories: braided and monofilament. While braided sutures are more commonly used due to better knot security, monofilaments are more popular in cardiovascular, neurological and ophthalmic surgeries. Companies have made constant efforts to come up with innovations to improve the quality of life for a patient. Firms that have headed the campaign for innovations include Abbott Vascular’s ProGlide, Perclose and Prostar suture-mediated devices.

Stapler devices have evolved from sutures, and though they possess the same function as sutures, the surgical procedure becomes easier and quicker using a stapling device. The market for stapler products has grown over the years since they are more precise, provide better safety and offer reduced recovery time than traditional sutures.

In terms of demand, mechanical wound closure devices follow after sutures in the global market.

However, with the demand for minimally invasive surgeries on the rise, the prospects for wound closure devices have dimmed. Minimal invasion means reduced usage of sutures, wound strips as well as mechanical wound closure devices. Minimally invasive surgeries also reduce the size of incisions made, thereby lowering the number of sutures required for closing otherwise large incisions.

On the other hand, the rise in plastic and cosmetic surgeries has led to a subsequent increase in demand for synthetic absorbable sutures.

Companies mentioned in the global wound closure devices market research report

The key players in the wound closure devices market include Sutura Inc., Teleflex Medical, Smith & Nephew, Radi Medical Systems, Ethicon Inc. (Johnson & Johnson), Abbott Vascular, Derma Sciences, and NeatStitch Ltd.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=179

Wednesday, 14 January 2015

Global Imaging Biomarkers Market - Industry Segment and Forecast, 2013 - 2019

Biomarkers also known as biological markers are characteristics that are measured in order to assess and predict biological condition of the body and thus help physicians in clinical decision making. Some major diseases which are diagnosed by using biomarkers include diabetes, cancer and cardiovascular and central nervous system diseases. Biomarkers play critical role in identifying and accurate diagnosis of these diseases at early stage and provide better treatment option. Imaging biomarkers can be classified as diagnostic biomarkers, monitoring biomarkers and predictive biomarkers. Diagnostic biomarkers are helpful in predicting a patient’s exact clinical outcome. Monitoring biomarkers provides clinical outcome of a patient after intake of a particular drug while predictive biomarkers help in predicting if a specific drug is likely to change clinical outcome of a patient.

Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Affymetrix Inc., Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann La Roche Ltd., Gen-Probe Inc., DiagnoCure Inc., and Siemens Healthcare are some major companies operating in the imaging biomarkers market and compete with each other in order to get competitive advantage. Small companies with breakthrough technologies attract large players to form alliances and thus help them gain advantages over their competitors.

Globally, the market for imaging biomarkers is evolving due to its increasing popularity and extensive use in drug discovery processes. The industry has witnessed a significant use of imaging biomarkers in the drug discovery process during the last few years owing to its ability to identifying disease mechanism and drug toxicity profiling. High prevalence of diseases such as cancer, Alzheimer’s disease, diabetes, rheumatoid arthritis and other slow progressing diseases are driving the imaging biomarkers market growth globally. According to Surveillance, Epidemiology, and End Results Program of National Cancer Institute, approximately 13,397,159 people were living with all cancer types in the United States in 2011. The study conducted by of National Cancer Institute further states that during 2014, around 1,666,540 new cases of cancer are expected to be witnessed in the United States and approximately 585,720 deaths because of all cancer sites. Statistics from American Diabetes Association suggests that approximately 26 million children and adults are living with diabetes in the United States. American Diabetes Association further states that nearly 1.9 people are diagnosed with diabetes every year in the country. On the basis of high prevalence and incidence rate associated with the above mentioned diseases, it can be concluded that rising prevalence of these diseases are likely to drive the market growth during the coming years. However, the market may face significant challenges due to significant variance in platforms available acrsoo multiple sites and Lack of standard data. High cost associated with the development of imaging biomarkers may also hamper the market growth to some extent.

Geographically, North America is the largest market for imaging biomarkers, followed by Europe, Asia-Pacific and Rest of the World (RoW). Well established healthcare infrastructure in the region is one of the key factors causing North America to lead the imaging biomarkers market globally. In Asia-Pacific region, the market is expected to grow under the influence of factors such as emerging economies (especially in India and China), continuously improving healthcare infrastructure and rising awareness regarding the imaging biomarkers and its application in drug discovery processes. Presence of large pool of patients living with various slow progressing diseases such as cancer and diabetes is also driving the market growth in the region.

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2381

Global Intra-Dialytic Hypotension Market - Industry Segment and Forecast till 2020

More Reports on Medical Devices Market : http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

Enquiry Before Buying :- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3164